Elective lymph node dissection (ELND) offers no significant survival benefit for all stage I melanoma patients. However, ELND significantly improves 5-year survival for intermediate thickness melanomas.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: